Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

Nature Medicine

Volumn 12, Issue 6, 2006, Pages 688-692

  Siragam, Vinayakumar ^a,b   Crow, Andrew R ^a,b   Brinc, Davor ^a,b   Song, Seng ^b   Freedman, John ^a,b,c,d   Lazarus, Alan H ^a,b,c,d  

^a CANADIAN BLOOD SERVICES   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Toronto Platelet Immunobiology Group   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; DRUG MECHANISM; FEMALE; HYPOTHESIS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD11C; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECEPTORS, IGG; SPLEEN;

EID: 33744989699     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1416     Document Type: Article

References (27)

1. Knezevic-Maramica, I. & Kruskall, M.S. Intravenous immune globulins: an update for clinicians. Transfusion 43, 1460-1480 (2003).
2. Jolles, S., Sewell, W.A. & Misbah, S.A. Clinical uses of intravenous immunoglobulin. Clin. Exp. Immunol. 142, 1-11 (2005).
3. McMillan, R., Longmire, R.L., Yelenosky, R., Donnell, R.L. & Armstrong, S. Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura. N. Engl. J. Med. 291, 812-817 (1974).
4. Saleh, M.N., Moore, D.L., Lee, J.Y. & LoBuglio, A.F. Monocyte-platelet interaction in immune and nonimmune thrombocytopenia. Blood 74, 1328-1331 (1989).
5. Semple, J.W. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev. 16, 9-12 (2002).
6. Bussel, J.B. Fc receptor blockade and immune thrombocytopenic purpura. Semin. Hematol. 37, 261-266 (2000).
7. Fehr, J., Hofmann, V. & Kappeler, U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N. Engl. J. Med. 306, 1254-1258 (1982).
8. Salama, A., Mueller-Eckhardt, C. & Kiefel, V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 2, 193-195 (1983).
9. Salama, A., Kiefel, V., Amberg, R. & Mueller-Eckhardt, C. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-RhO(D)). Blut 49, 29-35 (1984).
10. Lazarus, A.M. & Crow, A.R. Mechanism of action of IVIG and anti-D in ITP. Transfus. Apher. Sci. 28, 249-255 (2003).
11. Samuelsson, A., Towers, T.L. & Ravetch, J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291, 484-486 (2001).
12. Crow, A.R. et al. IVIg-mediated amelioration of murine ITP via Fc{gamma}RIIB is independent of SHIP1, SHP-1, and Btk activity. Blood 102, 558-560 (2003).
13. Siragam, V. et al. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? J. Clin. Invest. 115, 155-160 (2005).
14. Korganow, A.S. et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10, 451-461 (1999).
15. Kouskoff, V. et al. Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811-822 (1996).
16. Bruhns, P., Samuelsson, A., Pollard, J.W. & Ravetch, J.V. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18, 573-581 (2003).
17. Cao, X. et al. The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages. J. Immunol. 172, 4851-4857 (2004).
18. Latour, S., Bonnerot, C., Fridman, W.H. & Daeron, M. Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit. J. Immunol. 149, 2155-2162 (1992).
19. De Andres, B. et al. Phosphoinositide breakdown is associated with Fc-gamma RII-mediated activation of 5′-lipoxygenase in murine eosinophils. J. Immunol. 146, 1566-1570 (1991).
20. Timms, J.F. et al. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol. Cell. Biol. 18, 3838-3850 (1998).
21. Boruchov, A.M. et al. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J. Clin. Invest. 115, 2914-2923 (2005).
22. Song, S., Crow, A.R., Siragam, V., Freedman, J. & Lazarus, A.M. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg. Blood 105, 1546-1548 (2005).
23. Crow, A.R., Song, S., Semple, J.W., Freedman, J. & Lazarus, A.H. IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity. Br. J. Haematol. 115, 679-686 (2001).
24. Braun-Moscovici, Y. & Furst, D.E. Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it? Curr. Opin. Rheumatol. 15, 237-245 (2003).
25. Arnal, C. et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J. Rheumatol. 29, 75-83 (2002).
26. Spisek, R., Gasova, Z. & Bartunkova, J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 46, 55-65 (2006).
27. Song, S., Crow, A.R., Freedman, J. & Lazarus, A.M. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG. Blood 101, 3708-3713 (2003).